4-[(3R)-5-(6-fluoro-1H-indol-3-yl)-1,1-dihydroxy-3-methyl-3H-1,2-benzothiazol-2-yl]piperidin-2-one
C21H22FN3O3S — CID 122529625
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(3R)-5-(6-fluoro-1H-indol-3-yl)-1,1-dihydroxy-3-methyl-3H-1,2-benzothiazol-2-yl]piperidin-2-one
4-[(3R)-5-(6-fluoro-1H-indol-3-yl)-1,1-dihydroxy-3-methyl-3H-1,2-benzothiazol-2-yl]piperidin-2-one (PubChem CID 122529625) has the molecular formula C21H22FN3O3S and a molecular weight of 415.49 g/mol. Its IUPAC name is 4-[(3R)-5-(6-fluoro-1H-indol-3-yl)-1,1-dihydroxy-3-methyl-3H-1,2-benzothiazol-2-yl]piperidin-2-one.
Molecular Properties
| Compound Name | 4-[(3R)-5-(6-fluoro-1H-indol-3-yl)-1,1-dihydroxy-3-methyl-3H-1,2-benzothiazol-2-yl]piperidin-2-one |
|---|---|
| PubChem CID | 122529625 |
| Molecular Formula | C21H22FN3O3S |
| Molecular Weight | 415.49 g/mol |
| Exact Mass | 415.14 |
| IUPAC Name | 4-[(3R)-5-(6-fluoro-1H-indol-3-yl)-1,1-dihydroxy-3-methyl-3H-1,2-benzothiazol-2-yl]piperidin-2-one |
| SMILES | C[C@@H]1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(O)(O)N1C1CCNC(=O)C1 |
| InChI | InChI=1S/C21H22FN3O3S/c1-12-17-8-13(18-11-24-19-9-14(22)3-4-16(18)19)2-5-20(17)29(27,28)25(12)15-6-7-23-21(26)10-15/h2-5,8-9,11-12,15,24,27-28H,6-7,10H2,1H3,(H,23,26)/t12-,15?/m1/s1 |
| InChIKey | BRRNEPHNKJWKMT-KEKZHRQWSA-N |
| XLogP | 4.65 |
| TPSA | 88.59 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.49 |
| LogP ≤ 5 | 4.65 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122529625 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.